Quantcast

Latest Carpuject Stories

2011-02-14 12:47:00

LAKE FOREST, Ill., Feb. 14, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that the company will present at two upcoming conferences: -- Raymond James 32nd Institutional Investors Conference March 8, 2011 (Tuesday) - Orlando, Fla. 9:15 a.m. Eastern time -- Barclays Capital 2011 Global Healthcare Conference March 16, 2011...

2011-02-03 11:01:00

LAKE FOREST, Ill., Feb. 3, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval of Topotecan Injection, the first solution formulation of the oncology drug approved in the United States. The medication is a generic version of Hycamtin®, which had 2010 U.S. sales of more than $140 million. Hospira's topotecan is indicated for treatment of small cell lung...

2011-01-25 12:50:00

LAKE FOREST, Ill., Jan. 25, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, will host a conference call to discuss its fourth-quarter and full-year 2010 results and projections for 2011 on Wednesday, Feb. 2, 2011, at 8 a.m. Central time. The company will release its fourth-quarter and full-year 2010 results earlier that morning, before the U.S. stock market open and the conference call. A live webcast of the...

2010-12-13 15:11:00

LAKE FOREST, Ill., Dec. 13, 2010 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the J.P. Morgan 29th Annual Healthcare Conference on Tuesday, Jan. 11, 2011, in San Francisco. The presentation is scheduled to begin at 10:30 a.m. Pacific time on Tuesday, Jan. 11, 2011. It will be available to all interested parties through a live audiocast accessible via the...

2010-11-22 11:10:00

LAKE FOREST, Ill., Nov. 22, 2010 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, announced today that Francois (Frans) L. Dubois has been named to the newly created position of senior vice president, Quality, effective Jan. 3, 2011. In this capacity, he will have overall responsibility for Hospira's global quality systems and serve as a member of Hospira's senior leadership team. He will report directly to Christopher...

2010-11-15 13:46:00

LAKE FOREST, Ill., Nov. 15, 2010 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced it has launched a two-gram vial of gemcitabine hydrochloride for injection. The oncology medication is a generic version of Eli Lilly's Gemzar®, which posted 2009 U.S. sales of nearly $750 million for the full range of standard presentations. Hospira's gemcitabine is approved by the U.S. Food and Drug...

2010-11-02 14:20:00

LAKE FOREST, Ill., Nov. 2, 2010 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that the company will present at the Piper Jaffray 22nd Annual Health Care Conference, Nov. 30, 2010, in New York City. The presentation is scheduled to begin at 10:00 a.m. Eastern time on Tuesday, Nov. 30, 2010. It will be available to all interested parties through a live audiocast accessible via the investor relations...

2010-10-21 11:00:00

LAKE FOREST, Ill., Oct. 21 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced the launch of piperacillin and tazobactam for injection in the United States. The medication is a generic version of Zosyn®, the world's leading injectable antibiotic, from Pfizer (Wyeth). Piperacillin and tazobactam injection posted 2009 U.S. sales of more than $855 million. Piperacillin and tazobactam for injection is...

2010-10-07 09:34:00

LAKE FOREST, Ill., Oct. 7 /PRNewswire-FirstCall/ -- Hospira (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the new national infusion pump and solutions and equipment agreements with Novation became effective Oct. 1, 2010. Novation is the leading healthcare supply contracting company of VHA Inc. and the University HealthSystem Consortium (UHC) and Provista. The contracts provide the members served by Novation with continued...

2010-09-27 13:24:00

LAKE FOREST, Ill., Sept. 27 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its third-quarter 2010 results on Tuesday, Oct. 26, 2010, at 8 a.m. Central time. The company will release its third-quarter results earlier that morning, before the U.S. stock market open and the conference call. A live webcast of the conference call and related...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related